Journals / Marmara Medical Journal / 2002 / Cilt: 15 - Sayı: 3

BETA-THALASSEMIA SYNDROMES, CLINICAL AND LABORATORY APPROACH

Pages
194–200
Publication Date
2016-12-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This condition is referred to as (3-thalassemia minor or (3-thalassemia trait.In this report clinical and laboratory findings of 13- thalassemia syndromes in childhood are reviewed.Key Words: Beta thalassemia, Childhood, Anemia, Hypocromic microcytic anemia

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The Beta ((3) thalassemia syndromes are a heterogeneous group of genetic disorders.
📊
Key Findings & Data:The incidence rate of (3-thalassemia carriers was stated to be 2 per cent in Turkey.
💡
Conclusion & Impact:This condition is referred to as (3-thalassemia minor or (3-thalassemia trait.In this report clinical and laboratory findings of 13- thalassemia syndromes in childhood are reviewed.Key Words: Beta thalassemia, Childhood, Anemia, Hypocromic microcytic anemia
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The Beta ((3) thalassemia syndromes are a heterogeneous group of genetic disorders. The frequency of thalassemia is dependent on the ethnic origins of the patient population. Turkey is located in a geographic area of the world where thalassemia syndromes are common. The incidence rate of (3-thalassemia carriers was stated to be 2 per cent in Turkey. Clinical manifestations are diverse and range from asymptomatic hypochromia and microcytosis to profound anemia leading to death in early childhood if untreated. Individuals who are homozygous for the (3-thalassemia genes have severe, transfusion-dependent anemia and are said to have (3-thalassemia major. Thalassemia intermedia is a condition in which the degree of hemolysis is milder even though the patient may have a deficiency of both (3 genes. Therefore, thalassemia intermedia is essentially a descriptive term that refers to minimal or no need for transfusions. The presence of one normal gene in the heterozygotes usually leads to enough normal (3-globin chain synthesis so that the affected individuals are usually asymptomatic with only a mild anemia. This condition is referred to as (3-thalassemia minor or (3-thalassemia trait.In this report clinical and laboratory findings of 13- thalassemia syndromes in childhood are reviewed.Key Words: Beta thalassemia, Childhood, Anemia, Hypocromic microcytic anemia

🔖

Cite This Article

TÜRKKAN, E., BERRAK, S. G., CANPOLAT, C. (2016). BETA-THALASSEMIA SYNDROMES, CLINICAL AND LABORATORY APPROACH. Marmara Medical Journal, Cilt: 15 - Sayı: 3, 194–200. https://ajindex.com/articles/688688

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. /. Edward JB, Patricia JVG. Thalassemia syndromes. In: Miller DR, ed. Blood Diseases of Infancy and Childhood. 7th ed. St. Louis, MO: Mosby-Year Book Inc., ¡990:460-498.
  2. Cooley TB, Lee F. Series of cases of splenomegaly in children with anemia and peculiar bone changes. Trans Am Fediatr Soc 1925;3 7:29. (citation) Aksoy M. The history of beta-thalassemia in Turkey. Turk J Fediatr 1991;33:195-197. Chernoff A. The distribution of the thalassemia gene: A historical review. Blood 1959; 14:899. (citation) Siniscalco M. Population genetics of haemoglobin variants, thalassaemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis. Bull WHO 1966:34:379. Tiurse G. Iron, the thalassaemias, and malaria. Lancet 1979:2:938-940.
  3. Hagel RL, Roth EF Jr. Malaria and red cell genetic defects. Blood 1989;74:1213-1221.
  4. Barrai I, Rosito A, Cappellozza G. Beta- thalassemia in the Fo Delta: selection, geography, and population structure. Am J Hum Genet 1984:36:1121 -1134. Angastiniotis M, Ryriakidou S, Hadjiminas M. The Cyprus thalassemia control program. Birth Defects Orig Artie Ser 1988:23:4 I 7-432.
  5. Çavdar AO, Arcasoy A.The incidence of - thalassemia and abnormal hemoglobins in Turkey. Acta flaematol 197!,-45:312-318.
  6. Bircan I, Sisli S, Guven A, et at. Hemoglobinopathies in the district of Antalya, Turkey. Fediatr Hematol Oncol 1993; 10:289- 291. Koçak R, Alparslan ZTi, Agridag G, Baslamisli E, Aksungur FD, Hollas S. The frequency of anaemia, iron deficiency, hemoglobin S and beta thalassemia in the south of Turkey. Eur J Epidemiol 1995; I 1:181-184.
  7. Tiathan DG, Gunn RB. Thalassemia: the consequences of unbalanced hemoglobin synthesis. Am J Med 1966:4 1:815-830.
  8. Weatherall DJ, Clegg JB, Naughton MA. Globin synthesis in thalassaemia: an in vitro study, nature 1965:208:1061-1065.
  9. Joshi W, Leb L, Piotrowski J, Fortier N, Snyder LM. Increased sensitivity of isolated alpha subunits of normal human hemoglobin to oxidative damage and crosslinkage with spectrin. J Lab Clin Med 1983; 102:46-52. McDonogh HT, nienhuis AW. The thalassemias. In: Nathan DG, Oski FA, eds. Hematology of infancy and childhood. Philadelphia: W. B. Saunders Company,:783-879. I 7. Orkin S. Molecular analysis of human disease: dissection of beta-thalassemia. Clin Res 1984;32:329-333. liazazian H. The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. Semin Hematol 1990:27:209-228.
  10. Nienhuis AW, Anagnou NP, Ley TJ. Advances in thalassemia researc